
I am pleased to share that I will be chairing the track "In Silico Oncology" at the conference VPH 2026 (Virtual Physiological Human 2026). The conference will be held in Milan, Italy from 1 to 4 September 2026. I am looking forward to engaging discussions and high-quality contributions! Abstract submissions are now open until March 2. 🔗 https://vph-conference.org/abstract-submission/ 📌 SAVE THE DATE 9th International Conference on the Virtual Physiological Human (VPH) 📍 September 1–4, Politecnico di Milano 🔗 https://vph-conference.org/ It is worth noting that in silico oncology in its form of in silico radiation oncology served as the concrete paradigm for the formal foundation of in silico medicine as a distinct discipline in 2002 through the publication Stamatakos et al., "In silico radiation oncology: combining novel simulation algorithms with current visualization techniques," in Proceedings of the IEEE, vol. 90, no. 11, pp. 1764-1777, Nov. 2002, doi: 10.1109/JPROC.2002.804685, https://ieeexplore.ieee.org/document/1046955). The open access accepted manuscript of the paper is available at https://zenodo.org/records/18317236 . Proceedings of the IEEE is a top-tier, peer-reviewed technology journal. More information on the emergence of in silico medicine and digital (virtual) twins in oncology and beyond is available in Stamatakos, G. (2026). History of the emergence of in silico medicine. Zenodo. https://doi.org/10.5281/zenodo.18328392 . Research Professor Georgios S. Stamatakos Father of In Silico Medicine https://doi.org/10.5281/zenodo.18328392 Institute of Communication and Computer Systems (ICCS) School of Electrical and Computer Engineering (ECE) National Technical University of Athens (NTUA) Director and Founder, In Silico Oncology and In Silico Medicine Group, ICCS, ECE, NTUA Visiting Professor, Medical School, University of Saarland, Germany (1/7–15/9/2019) Visiting Professor, ECE, NTUA (2016-2019) Co-Chair, Cancer and In Silico Oncology Task Force, Avicenna Alliance - Association for Predictive Medicine Editor, Scientific Reports, Nature Portfolio Iroon Polytechniou 9, GR 157 80 Zografos, Greece E-Mail: gestam@central.ntua.gr , Tel. +30 210 7722287, www.in-silico-oncology.iccs.ntua.gr
vph, medicine, virtual twin, Virtual Human Twin, in silico clinical studies, in silico oncology, in silico medicine, AI, digital twin, biomedical engineering, oncology, computational medicine, genetics, Artificial Inteligence, VHT, in silico clinical trials
vph, medicine, virtual twin, Virtual Human Twin, in silico clinical studies, in silico oncology, in silico medicine, AI, digital twin, biomedical engineering, oncology, computational medicine, genetics, Artificial Inteligence, VHT, in silico clinical trials
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
